Salient Bio is a London-based laboratory driven by a passionate, multidisciplinary team with over 70 years of combined experience in synthetic biology and systems automation. A key focus of their research and development (R&D) is advancing microbiome reporting. The microbiome, a diverse community of microorganisms, plays a crucial role in health and wellbeing.

Salient Bio provides a broad range of short-read sequencing techniques, customised to fit specific research needs. Their services encompass the popular 16S rRNA amplicon sequencing and offer shotgun sequencing at varying depths, ensuring adaptability and accuracy across different applications. They collaborate to identify the most appropriate method for each project. Additionally, Salient Bio can offer long-read sequencing options when required, enabling more comprehensive and in-depth analysis.

Research Commitment

‍Through significant investment in R&D, healthcare providers gain access to award-winning tests that offer detailed insights into patients' microbiomes. Salient Bio believes in the importance of preventive healthcare and advocates for broad access to both traditional and advanced diagnostic testing. They are building innovative, future-ready labs, operating high-throughput, state-of-the-art laboratories and diagnostic services in Central London with a tech-enabled, digital-first approach. Their molecular biology diagnostic workflows are fast, reliable, and cutting-edge, designed to meet customer needs.

As the healthcare landscape evolves, so do the demands of professionals and patients. Salient Bio's commitment to R&D ensures that their tests and reporting tools are not only current but also adaptable to the changing needs of the industry. For them, R&D is not just about innovation—it is about delivering relevance, precision and value to every client they serve.

UKAS-accredited